Anebulo Pharmaceuticals Inc. (ANEB) Statistics & Valuation Metrics - Stocknear

Anebulo Pharmaceuticals I...

NASDAQ: ANEB · Real-Time Price · USD
2.40
-0.04 (-1.64%)
At close: Sep 26, 2025, 3:59 PM
2.40
0.00%
After-hours: Sep 26, 2025, 04:10 PM EDT

Anebulo Pharmaceuticals Statistics

Share Statistics

Anebulo Pharmaceuticals has 41.08M shares outstanding. The number of shares has increased by 58.43% in one year.

41.08M
58.43%
0%
55.05%
24.43M
4,532
1.04%

Short Selling Information

The latest short interest is 404.33K, so 0.98% of the outstanding shares have been sold short.

404.33K
0.98%
5.78%
2.4

Valuation Ratios

The PE ratio is -8.44 and the forward PE ratio is -5.08. Anebulo Pharmaceuticals's PEG ratio is 0.26.

-8.44
-5.08
0
5.9
18.15
-8.55
0.26
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Anebulo Pharmaceuticals.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 13.46, with a Debt / Equity ratio of 0.

13.46
13.46
0
n/a
n/a
-54.94

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
n/a
$-4.1M
2
0
n/a

Taxes

n/a
0%

Stock Price Statistics

The stock price has increased by 17.07% in the last 52 weeks. The beta is -0.89, so Anebulo Pharmaceuticals's price volatility has been lower than the market average.

-0.89
17.07%
2.51
1.64
48.97
433,871

Income Statement

n/a
n/a
-8.31M
-8.2M
-8.05M
-8.05M
-0.32
Full Income Statement

Balance Sheet

The company has 3.09M in cash and 0 in debt, giving a net cash position of 3.09M.

3.09M
n/a
n/a
-65.4M
14.01M
13.26M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.09M and capital expenditures 0, giving a free cash flow of -8.09M.

-8.09M
n/a
-8.09M
-0.31
Full Cash Flow Statement

Margins

n/a
n/a
n/a
n/a
n/a
n/a
n/a

Dividends & Yields

ANEB does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for ANEB is $8, which is 233.3% higher than the current price. The consensus rating is "Hold".

$8
233.3%
Hold
2
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Scores

84.73
2